Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular

The latest in CLL from EHA 2016

Prof Peter Hillmen, Prof Paolo Ghia, Dr Chris Fox and Dr Constantine Tam
The latest in CLL from EHA 2016 ( Prof Peter Hillmen, Prof Paolo Ghia, Dr Chris Fox and Dr Constantine Tam )
11 Jun 2016

An overview of MCL from EHA 2016

Professor Simon Rule and Professor Steven Le Gouill
An overview of MCL from EHA 2016 ( Professor Simon Rule and Professor Steven Le Gouill )
10 Jun 2016

ASCO 2016: What is the optimal chemotherapy dosing regimen for prostate cancer?

Prof Charles Ryan and Prof Nick James
ASCO 2016: What is the optimal chemotherapy dosing regimen for prostate cancer? ( Prof Charles Ryan and Prof Nick James )
6 Jun 2016

Global drug pricing: How cost-effective is bevacizumab?

Dr Daniel Goldstein - Emory University, Atlanta, USA
Global drug pricing: How cost-effective is bevacizumab? ( Dr Daniel Goldstein - Emory University, Atlanta, USA )
6 Jun 2016

Update on olaparib in ovarian cancer

Prof Jonathan Ledermann - University College Hospital Medical School, London, UK
Update on olaparib in ovarian cancer ( Prof Jonathan Ledermann - University College Hospital Medical School, London, UK )
6 Jun 2016

Impact of precision medicine in refractory malignancies

Prof Maria Schwaederle - University of California, San Diego, USA
Impact of precision medicine in refractory malignancies ( Prof Maria Schwaederle - University of California, San Diego, USA )
6 Jun 2016

Photon vs proton beam therapy: modality in radiotherapy for non-small cell lung cancer

Dr Madhusmita Behera - Emory University, Atlanta, USA
Photon vs proton beam therapy: modality in radiotherapy for non-small cell lung cancer ( Dr Madhusmita Behera - Emory University, Atlanta, USA )
6 Jun 2016

Phase I study of sapacitabine and seliciclib in patients with advanced solid tumours

Dr Sara Tolaney - Dana Farber Cancer Institute, Boston, USA
Phase I study of sapacitabine and seliciclib in patients with advanced solid tumours ( Dr Sara Tolaney - Dana Farber Cancer Institute, Boston, USA )
6 Jun 2016

Elderly patients with glioblastoma live longer with chemoradiation using temozolomide

Prof James Perry - University of Toronto, Toronto, Canada
Elderly patients with glioblastoma live longer with chemoradiation using temozolomide ( Prof James Perry - University of Toronto, Toronto, Canada )
5 Jun 2016

Patients with advanced bladder cancer benefit from anti-PD-L1 immunotherapy

Dr Arjun Balar - NYU Langone Medical Center, New York, USA
Patients with advanced bladder cancer benefit from anti-PD-L1 immunotherapy ( Dr Arjun Balar - NYU Langone Medical Center, New York, USA )
5 Jun 2016

METEOR trial: cabozantinib vs everolimus in advanced renal cell carcinoma

Dr Toni Choueiri - Dana Farber Cancer Institute, Boston, USA
METEOR trial: cabozantinib vs everolimus in advanced renal cell carcinoma ( Dr Toni Choueiri - Dana Farber Cancer Institute, Boston, USA )
5 Jun 2016

Extending adjuvant letrozole for 5 years after completing an initial 5 years of aromatase inhibitor therapy alone

Dr Paul Goss - Massachusetts General Hospital Cancer Center, Boston, USA
Extending adjuvant letrozole for 5 years after completing an initial 5 years of aromatase inhibitor therapy alone ( Dr Paul Goss - Massachusetts General Hospital Cancer Center, Boston, USA )
5 Jun 2016

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation